47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.31.Z - Real estate brokerage
69.20.Z - Accounting, bookkeeping and tax consultancy
73.12.D - Advertising through mass media
82.99.Z - Other business support activities, not elsewhere classified
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,2 | 3,4 | 5,3 | 55,3 |
EBITDA | 3,9 | 4 | 4,5 | 13,2 |
Short time liabilities | 12,7 | 10 | 8,7 | -13,2 |
Equity capital | 1,5 | 1,6 | 5 | 222,7 |
Operating profit (EBIT) | 3,4 | 3,5 | 4,1 | 15,4 |
Assets | 15,4 | 15,7 | 14,5 | -7,3 |
Net profit (loss) | 3,2 | 3,4 | 5,3 | 55,3 |
Cash | 1,7 | 3,4 | 1,7 | -49,5 |
Liabilities and provisions for liabilities | 13,9 | 14,1 | 9,5 | -32,6 |
Net income from sale | 67,1 | 68 | 69,9 | 2,8 |
Working assets | 10,4 | 11,3 | 10,6 | -6,6 |
Depreciation | 0,5 | 0,4 | 0,4 | -4,6 |
% | % | % | p.p. | |
Profitability of capital | 206,2 | 218 | 104,9 | -113,1 |
Equity capital to total assets | 10 | 9,9 | 34,5 | 24,6 |
Gross profit margin | 4,7 | 5 | 7,5 | 2,5 |
EBITDA Margin | 5,8 | 5,9 | 6,5 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 69 | 54 | 45 | -9 |
Current financial liquidity indicator | 0.8155369162559509 | 0,1 | ||
Net dept to EBITDA | 0.803956151008606 | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane